By Connor Hart
Codexis has named Georgia Erbez as its chief financial officer, succeeding Sri Ryali.
Erbez most recently served as chief operating officer at Walking Fish Therapeutics, a private B-cell therapy company. Prior, she has held executive roles at companies including Harpoon Therapeutics, Zosano Pharma and Revolution Medicines, the enzyme-engineering company said Wednesday.
Codexis also named Alison Moore to the newly-created role of chief technology officer, and named John Schiffhauer as senior vice president of intellectual property.
Also on Wednesday, the company announced an increase in its cash reserves through capital raises totaling $31 million.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
October 02, 2024 16:24 ET (20:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。